Updated:
Scienture Holdings, Inc.
Scienture Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001382574, and its reported...
Overview
Scienture Holdings, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001382574, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-30, it reported annual revenue of USD 431,609; net income of USD -41,512,264; total assets of USD 84,178,330 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Scienture Holdings, Inc.
- Former names in filing history
- TRxADE HEALTH, INC (2021-06-02 to 2024-08-28); TRXADE GROUP, INC. (2014-06-11 to 2021-05-28); XCELLINK INTERNATIONAL INC. (2008-11-18 to 2014-01-31); Bluebird Exploration Co. (2007-06-15 to 2008-12-10)
- Classification
- Public company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Commack, NY, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: SCNX
- SEC CIK
- 0001382574
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $431,609 | -$41.5M | $84.2M | $6.7M | -$13.4M | |
| FY2024USD | $136,643 | $9.1M | $104.9M | — | -$14.3M | |
| FY2023USD | $8.3M | -$17.8M | $12.5M | $151,908 | — | |
| FY2022USD | $11.4M | -$3.5M | $3.7M | $1.1M | -$1.5M |
FY2025. Net income: shown as originally filed; later filings report different values for the same periods.
FY2024. Net income: shown as originally filed; later filings report different values for the same periods.
FY2023. Revenue, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2022. Revenue, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K/A | 10-K/A | ||
| 10-K | 10-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Scienture Holdings, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.